Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The BIG Study for Depression
NCT04181736Phase 4Completed
- Sponsor
- Stanford University
- Start
- Sep 2022
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of guanfacine in major depressive disorder (MDD), sponsored by Stanford University. Started Sep 2022; status: completed.
02
Drugs
guanfacine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04181736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04181736.